Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
L. Laine, W.L. Peterson.
Bleeding peptic ulcer.
N Engl J Med, 331 (1994), pp. 717-727
[2.]
M. Mignon, J.G. Penston, M. Deltenre, P. Ruszniewski, G. Dobrill.
Natural history of duodenal ulcer disease: are we at a turning point?.
Gastroenterol Int, 7 (1994), pp. 95-113
[3.]
H. Petersen, P. Kristensen, T. Johannessen, P.M. Kleveland, J.H. Dybdahl, H. Myrvold.
The natural course of peptic ulcer disease and its predictors.
Scand J Gastroenterol, 30 (1995), pp. 17-24
[4.]
L.A. Laine.
Helicobacter pylori and complicated ulcer disease.
Am J Med, 100 (1996), pp. 52S-57S
[5.]
D.A. Gilbert.
Epidemiology of upper gastrointestinal bleeding.
Gastrointest Endosc, 36 (1990), pp. S8-13
[6.]
J.G. Penston, K.G. Wormsley.
Review article: maintenance treatment with H2-receptor antagonists for peptic ulcer disease.
Aliment Pharmacol Ther, 6 (1992), pp. 3-29
[7.]
W.R. Murray, G. Cooper, G. Laferla, P. Rogers, M. Archibald.
Maintenance ranitidine treatment after haemorrhage from a duodenal ulcer. A 3-year study.
Scand J Gastroenterol, 23 (1988), pp. 183-187
[8.]
D.M. Jensen, S. Cheng, T.O. Kovacs, G. Randall, M.E. Jensen, T. Reedy, et al.
A controlled study of ranitidine for the prevention of recurrent hemorrhage from duodenal ulcer.
N Engl J Med, 330 (1994), pp. 382-386
[9.]
J.P. Gisbert, D. Boixeda, C. Martín de Argila, A. García Plaza.
Helicobacter pylori y úlcera duodenal: ¿relación causal o mera asociación?.
Rev Clin Esp, 197 (1997), pp. 693-702
[10.]
E.J. Kuipers, J.C. Thijs, H.P. Festen.
The prevalence of Helicobacter pylori in peptic ulcer disease.
Aliment Pharmacol Ther, 9 (1995), pp. 59-69
[11.]
J.P. Gisbert, J.M. Pajares.
Helicobacter pylori and bleeding peptic ulcer: what is the prevalence of the infection in patients with this complication?.
Scand J Gastroenterol, 38 (2003), pp. 2-9
[12.]
R.J. Hopkins, L.S. Girardi, E.A. Turney.
Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review.
Gastroenterology, 110 (1996), pp. 1244-1252
[13.]
NIH Consensus Conference.
Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease.
JAMA, 272 (1994), pp. 65-69
[14.]
A.H. Soll.
Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology.
JAMA, 275 (1996), pp. 622-629
[15.]
J.P. Gisbert, S. Khorrami, F. Carballo, X. Calvet, E. Gene, J.E. Domínguez-Muñoz.
H. pylori eradication therapy versus antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer.
Cochrane Database Syst Rev, (2004),
[16.]
J.P. Gisbert, S. Khorrami, F. Carballo, X. Calvet, E. Gene, E. Domínguez-Muñoz.
Helicobacter pylori eradication therapy versus antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer.
Aliment Pharmacol Ther, 19 (2004), pp. 617-629
[17.]
P.E. Arkkila, K. Seppala, T.U. Kosunen, R. Haapiainen, E. Kivilaakso, P. Sipponen, et al.
Eradication of Helicobacter pylori improves the healing rate and reduces the relapse rate of nonbleeding ulcers in patients with bleeding peptic ulcer.
Am J Gastroenterol, 98 (2003), pp. 2149-2156
[18.]
S. Bataga, B. Bratu, L. Bancu, C. Haydu, I. Torok, C. Dudea.
The treatment in bleeding duodenal ulcer.
Gut, 41 (1997), pp. A167
[19.]
D.Y. Graham, K.S. Hepps, F.C. Ramírez, G.M. Lew, Z.A. Saeed.
Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease.
Scand J Gastroenterol, 28 (1993), pp. 939-942
[20.]
D. Jaspersen, T. Koerner, W. Schorr, M. Brennenstuhl, C. Raschka, C.H. Hammar.
Helicobacter pylori eradication reduces the rate of rebleeding in ulcer hemorrhage.
Gastrointest Endosc, 41 (1995), pp. 5-7
[21.]
K.C. Lai, W.M. Hui, W.M. Wong, B.C. Wong, W.H. Hu, C.K. Ching, et al.
Treatment of Helicobacter pylori in patients with duodenal ulcer hemorrhage -a long-term randomized, controlled study.
Am J Gastroenterol, 95 (2000), pp. 2225-2232
[22.]
T. Rokkas, A. Karameris, A. Mavrogeorgis, E. Rallis, N. Giannikos.
Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease.
Gastrointest Endosc, 41 (1995), pp. 1-4
[23.]
A. Vcev, D. Horvat, M. Rubinic, D. Stimac, A. Vceva, M. Uravic, et al.
Eradication of Helicobacter pylori reduces the possibility of rebleeding in duodenal ulcer disease.
Acta Fam med Flum, 21 (1996), pp. 59-65
[24.]
J.F. Riemann, D. Schilling, P. Schauwecker, G. Wehlen, D. Dorlars, B. Kohler, et al.
Cure with omeprazole plus amoxicillin versus long-term ranitidine therapy in Helicobacter pylori-associated peptic ulcer bleeding.
Gastrointest Endosc, 46 (1997), pp. 299-304
[25.]
C. Santander, R.G. Gravalos, A. Gómez-Cedenilla, J. Cantero, J.M. Pajares.
Antimicrobial therapy for Helicobacter pylori infection versus long-term maintenance antisecretion treatment in the prevention of recurrent hemorrhage from peptic ulcer: prospective nonrandomized trial on 125 patients.
Am J Gastroenterol, 91 (1996), pp. 1549-1552
[26.]
J.J. Sung, W.K. Leung, R. Suen, V.K. Leung, F.K. Chan, T.K. Ling, et al.
One-week antibiotics versus maintenance acid suppression therapy for Helicobacter pylori-associated peptic ulcer bleeding.
Dig Dis Sci, 42 (1997), pp. 2524-2528
[27.]
V.K. Sharma, A.V. Sahai, F.A. Corder, C.W. Howden.
Helicobacter pylori eradication is superior to ulcer healing with or without maintenance therapy to prevent further ulcer haemorrhage.
Aliment Pharmacol Ther, 15 (2001), pp. 1939-1947
[28.]
J.P. Gisbert, J.M. Pajares.
Helicobacter pylori ‘rescue’ regimen when proton pump inhibitor-based triple therapies fail.
Aliment Pharmacol Ther, 16 (2002), pp. 1047-1057
[29.]
L. Laine.
The long-term management of patients with bleeding ulcers: Helicobacter pylori eradication instead of maintenance antisecretory therapy.
Gastrointest Endosc, 41 (1995), pp. 77-79
[30.]
J.P. Gisbert, J.M. Pajares, R. García-Valriberas, V. Abraira, D. Boixeda, R. García-Gravalos, et al.
Recurrence of Helicobacter pylori infection after eradication: incidence and variables influencing it.
Scand J Gastroenterol, 33 (1998), pp. 1144-1151
[31.]
D. Jaspersen, T. Korner, W. Schorr, M. Brennenstuhl, C.H. Hammar.
Omeprazole-amoxycillin therapy for eradication of Helicobacter pylori in duodenal ulcer bleeding: preliminary results of a pilot study.
J Gastroenterol, 30 (1995), pp. 319-321
[32.]
G.H. Elta.
Helicobacter pylori reinfection: what’s the risk?.
Gastroenterology, 107 (1994), pp. 1563-1564
[33.]
H.X. Xia, N.J. Talley, C.T. Keane, C.A. O’Morain.
Recurrence of Helicobacter pylori infection after successful eradication: nature and possible causes.
Dig Dis Sci, 42 (1997), pp. 1821-1834
[34.]
J. Huelin Benítez, M. Jiménez Pérez, A. Durán Campos, P. España Contreras, J. De la Cruz Lombardo, J.M. Lozano Rey, et al.
Haemorrhagic relapse in duodenal ulcers after eradication of Helicobacter pylori.
Gut, 43 (1998), pp. A101
[35.]
J.S. Barthel.
Bleeding ulcers and Helicobacter pylori.
Gastrointest Endosc, 46 (1997), pp. 371-373
[36.]
M. Amendola, R. Farias, J. Katz, P. Luna, M. Ianella, A. Musi, et al.
Absence of bleeding recurrence of peptic ulcer after long term follow-up of successful eradication of Helicobacter pylori.
Acta Gastroenterol Latinoam, 29 (1999), pp. 47-50
[37.]
F. Di Mario, S. Salandin, S. Kusstatscher, N. Dal Bo, A. Buda, M. Franceschi, et al.
Eradication of Helicobacter pylori infection in preventing peptic ulcer bleeding.
Gut, 41 (1997), pp. 203A
[38.]
S. Fakhreih, M. Rahemi, N. Dehbashi, M.S. Firoozi, A.A. Keshavarz, I. Albborzi, et al.
Eradication of Helicobacer pylori versus ranitidine maintenance therapy for prevention of duodenal ulcer rebleeding.
Gut, 37 (1995), pp. A236
[39.]
J.P. Gisbert, D. Boixeda, R. Aller, C. De la Serna, E. Sanz, C. Martín de Argila, et al.
Helicobacter pylori y hemorragia digestive por úlcera duodenal: prevalencia de la infección, eficacia de tres terapias triples y papel de la erradicación en la prevención de la recidiva hemorrágica.
Med Clin (Barc), 112 (1999), pp. 161-165
[40.]
I. Krizman, M. Ribnikar, F. Kozjek, S. Primozic.
Comparative amoxicillin - Azithromycin treatment of Helicobacter pylori positive patients with bleeding duodenal ulcer.
Acta Pharmaceutica, 47 (1997), pp. 183-188
[41.]
J. Labenz, G. Borsch.
Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse.
Digestion, 55 (1994), pp. 19-23
[42.]
K.C. Lai, W.M. Hui, S.K. Lam, B.C.Y. Wong, K.M. Chu, W.M. Wong, et al.
Maintenance H2-antagonist is not necessary after eradication of Helicobacer pylori in bleeding peptic ulcers.
Gastroenterology, 114 (1998), pp. 192A
[43.]
C. Lee, C.H. Wu, T.K. Chen, T.C. Tu, C.C. Chan, S.C. Lee.
Maintenance anti-ulcer treatment is not necessary in patients with bleeding peptic ulcer after H. pylori eradication and ulcer healing.
Gut, 45 (1999), pp. 116A
[44.]
S. Loperfido, R. Priora, F. Monica, H.H. Salvat.
Effect of Helicobacter pylori eradication on recurrence of bleeding duodenal ulcer and dyspeptic symptoms: a two-year prospective study.
Gastroenterology, 120 (2001), pp. 585A
[45.]
G. Macri, S. Milani, E. Surrenti, M.T. Passaleva, G. Salvadori, C. Surrenti.
Eradication of Helicobacter pylori reduces the rate of duodenal ulcer rebleeding: a long-term follow-up study.
Am J Gastroenterol, 93 (1998), pp. 925-927
[46.]
S. Pamos, M. Lujan, P. Canelles, E. Orti, F. Quiles, A. Tome.
Erradicación del Helicobacter pylori y recidiva hemorrágica por ulcus gástrico.
Rev Esp Enferm Dig, 90 (1998), pp. 136
[47.]
P. Pazzi, R. Scagliarini, S. Gamberini, C. Rizzo, S. Gullini.
Helicobacter pylori (Hp) eradication and reduction of duodenal ulcer (DU) bleeding relapse: a 4-year follow-up study.
Gastroenterology, 116 (1999), pp. 278A
[48.]
R. Pellicano, S. Peyre, N. Leone, A. Repici, C. De Angelis, R. Rizzi, et al.
The effect of the eradication of Helicobacter pylori infection on hemorrhage because of duodenal ulcer.
J Clin Gastroenterol, 32 (2001), pp. 222-224
[49.]
R. Pica, M. Marigani, G. D’Ambra, R. Cavilia, G. Antonelli, B. Annibale, et al.
One year H. pylori eradication in duodenal ulcer (DU) hypersecretory patients does not alter acid secretion but prevents ulcer relapse and bleeding.
Gastroenterology, 111 (1996), pp. 250A
[50.]
M. Vergara, F. Casellas, E. Saperas, I. De Torres, J. López, N. Borruel, et al.
Helicobacter pylori eradication prevents recurrence from peptic ulcer haemorrhage.
Eur J Gastroenterol Hepatol, 12 (2000), pp. 733-737
[51.]
C.C. Liu, C.L. Lee, C.C. Chan, T.C. Tu, C.C. Liao, C.H. Wu, et al.
Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
Arch Intern Med, 163 (2003), pp. 2020-2024
[52.]
D.M. Jensen, T. Savides, M. Sitzer, H. Frankl, K. Esrason, S. Hamamah, et al.
Prevention of ulcer hemorrhage by H. pylori eradication.
Gastroenterology, 124 (2003), pp. 135
[53.]
G. Capurso, B. Annibale, J. Osborn, G. D’Ambra, G. Martino, E. Lahner, et al.
Occurrence and relapse of bleeding from duodenal ulcer: respective roles of acid secretion and Helicobacter pylori infection.
Aliment Pharmacol Ther, 15 (2001), pp. 821-829
[54.]
J.P. Gisbert, R. García-Grávalos, D. Olivares, F. Feu, J.M. Piqué, F. Bory, et al.
Erradicación de Helicobacter pylori y prevención de la recidiva hemorrágica por úlcera péptica.
Gastroenterol Hepatol, 28 (2005), pp. 156
[55.]
K.E. McColl.
The role of Helicobacter pylori eradication in the management of acute bleeding peptic ulcer.
Eur J Gastroenterol Hepatol, 7 (1995), pp. 753-755
[56.]
L. Lachman, C.W. Howden.
Twenty-four-hour intragastric pH: tolerance within 5 days of continuous ranitidine administration.
Am J Gastroenterol, 95 (2000), pp. 57-61
[57.]
A.G. Johnson.
Proximal gastric vagotomy: does it have a place in the future management of peptic ulcer?.
World J Surg, 24 (2000), pp. 259-263
[58.]
A. Sonnenberg, C.A. Olson, J. Zhang.
The effect of antibiotic therapy on bleeding from duodenal ulcer.
Am J Gastroenterol, 94 (1999), pp. 950-954
[59.]
G. Holtmann, C.W. Howden.
Review article: management of peptic ulcer bleeding-the roles of proton pump inhibitors and Helicobacter pylori eradication.
Aliment Pharmacol Ther, 19 (2004), pp. 66-70
[60.]
A. Barkun, C.A. Fallone, N. Chiba, M. Fishman, N. Flook, J. Martin, et al.
A Canadian clinical practice algorithm for the management of patients with nonvariceal upper gastrointestinal bleeding.
Can J Gastroenterol, 18 (2004), pp. 605-609
[61.]
J.P. Gisbert, L. González, A. De Pedro, M. Valbuena, B. Prieto, I. Llorca, et al.
Helicobacter pylori and bleeding duodenal ulcer: prevalence of the infection and role of non-steroidal anti-inflammatory drugs.
Scand J Gastroenterol, 36 (2001), pp. 717-724
[62.]
P. Grino, S. Pascual, J. Such, J.A. Casellas, M. Niveiro, M. Andreu, et al.
Comparison of diagnostic methods for Helicobacter pylori infection in patients with upper gastrointestinal bleeding.
Scand J Gastroenterol, 36 (2001), pp. 1254-1258
[63.]
A. García-Altes, A.J. Jovell, M. Serra-Prat, M. Aymerich.
Management of Helicobacter pylori in duodenal ulcer: a cost-effectiveness analysis.
Aliment Pharmacol Ther, 14 (2000), pp. 1631-1638
[64.]
A.M. Fendrick, M.E. Chernew, R.A. Hirth, B.S. Bloom.
Alternative management strategies for patients with suspected peptic ulcer disease.
Ann Intern Med, 123 (1995), pp. 260-268
[65.]
F. Feu, E. Brullet, X. Calvet, J. Fernández-Llamazares, J. Guardiola, P. Moreno, et al.
Guidelines for the diagnosis and treatment of acute non-variceal upper gastrointestinal bleeding.
Gastroenterol Hepatol, 26 (2003), pp. 70-85
[66.]
R. Marmo, G. Rotondano, M.A. Bianco, L. Cipolletta.
Helicobacter pylori and bleeding peptic ulcer: do we really need a gold standard?.
Gastrointest Endosc, 52 (2000), pp. 148-149
[67.]
Gené E, Calvet X, Gisbert JP. Which is the best strategy to eradicate Helicobacter pylori in bleeding peptic ulcer? A cost-effectiveness analysis. Aliment Pharmacol Ther. En prensa.
[68.]
U.C. Ghoshal, R. Aggarwal, C.S. Baba.
Recurrent duodenal ulcer haemorrhage: a pharmacoeconomic comparison of various management strategies.
Expert Opin Pharmacother, 4 (2003), pp. 1593-1603
[69.]
J. Ofman, J. Wallace, E. Badamgarav, C.F. Chiou, J. Henning, L. Laine.
The cost-effectiveness of competing strategies for the prevention of recurrent peptic ulcer hemorrhage.
Am J Gastroenterol, 97 (2002), pp. 1941-1950
[70.]
E. Gene, X. Calvet, R. Azagra, T. López, M.J. Cubells.
Manejo de la dispepsia, la enfermedad ulcerosa y la infección por Helicobacter pylori en atención primaria.
Aten Primaria, 29 (2002), pp. 486-494
[71.]
P.S. Phull, D. Halliday, A.B. Price, M.R. Jacyna.
Absence of dyspeptic symptoms as a test of Helicobacter pylori eradication.
BMJ, 312 (1996), pp. 349-350
[72.]
E. Gene, X. Calvet, R. Azagra.
Diagnosis of Helicobacter pylori after triple therapy in uncomplicated duodenal ulcers-a cost-effectiveness analysis.
Aliment Pharmacol Ther, 14 (2000), pp. 433-442
[73.]
H. Pohl, S.R. Finlayson, A. Sonnenberg, D.J. Robertson.
Helicobacter pylori-associated ulcer bleeding: should we test for eradication after treatment?.
Gastroenterology, 126 (2004), pp. 1270W
[74.]
H.M. Hood, C. Wark, P.A. Burgess, D. Nicewander, M.W. Scott.
Screening for Helicobacter pylori and nonsteroidal anti-inflammatory drug use in medicare patients hospitalized with peptic ulcer disease.
Arch Intern Med, 159 (1999), pp. 149-154
[75.]
K. Garrigan, C. McIntosh, A.G. Fraser.
Bleeding peptic ulcers: audit of eradication treatment for H. pylori.
NZ Med J, 112 (1999), pp. 178-180
[76.]
M.E. Van Leerdam, G.N. Tytgat.
Review article: Helicobacter pylori infection in peptic ulcer haemorrhage.
Aliment Pharmacol Ther, 16 (2002), pp. 66-78
Esta revisión ha sido realizada en parte gracias a una beca concedida por el Instituto de Salud Carlos III (C03/02).
Copyright © 2005. Elsevier España S.L.. Todos los derechos reservados
